Search for: "Johnson " Results 7521 - 7540 of 32,312
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Jul 2015, 2:51 pm by Dr. Shezad Malik
Johnson & Johnson’s Janssen Pharmaceuticals unit manufactures and distributes Invokana (canagliflozin), for patients with type-2 diabetes, to control their blood-sugar levels. [read post]
26 Mar 2016, 7:15 am by Associates and Bruce L. Scheiner
Johnson & Johnson, along with its subsidiary DePuy, recently lost a $500 million lawsuit in a consolidated case of five Texas patients who suffered serious injury as a result of defective hip implants. [read post]
2 Nov 2011, 7:51 pm
In August 2010, the DePuy Orthopaedic division of Johnson & Johnson recalled the ASR XL Acetabular and Hip Resurfacing Systems due to a high failure rate compared to traditional hip implants. [read post]
6 Oct 2015, 9:38 am by Ronald V. Miller, Jr.
 A Texas jury yesterday found for Johnson & Johnson’s (J&J) Ethicon division in a pelvic mesh claim. [read post]
22 Nov 2022, 7:22 am by Geoff Schweller
CFTC Commissioner Kristin Johnson told Bloomberg “in the context of the digital-asset space, the value of having those vocal whistleblowers and tipsters is critical. [read post]
24 May 2017, 5:12 am by Moll Law Group
This month, the Judicial Panel on Multidistrict Litigation (JPML) will hear arguments regarding whether to consolidate the numerous pending cases against Ethicon, a subsidiary of Johnson & Johnson, regarding its physiomesh products. [read post]
12 Sep 2016, 7:48 am by Law Offices of Jeffrey S. Glassman
The makes of Xarelto (Bayer and Johnson & Johnson) took a major hit this week in terms of the future of there flagship drug. [read post]
6 Oct 2017, 9:32 am by Jeff Rasansky
In collaboration with Johnson & Johnson, the DePuy Orthopedics developed a device in 2005 which sought to alleviate issues brought on by hip degradation. [read post]
12 Oct 2010, 9:26 am
On August 26, 2010, the Johnson & Johnson subdivision known as DePuy recalled the DePuy ASR Hip Replacement System due to the overwhelming number of individuals who have experienced serious complications due to the implant. [read post]
8 Feb 2009, 2:55 am
Plaintiff, part of the team of Masters and Johnson, is the owner of a service mark for "Masters and Johnson," licensed to clinics who use the teachings, research, principles, and methodology they developed in the diagnosis and treatment of sexual disorders. [read post]
22 Feb 2016, 5:59 am by Law Offices of Jeffrey S. Glassman
Xarelto, with a generic name rivaroxaban, is making hundreds of millions of dollars for Beyer and Janssen (a wholly owned Johnson & Johnson subsidiary), and these companies will take any chance they can get to increased sales. [read post]
Johnson & Johnson Consumer Companies, Inc., Langan, a Connecticut resident, sued J&J for violating the Connecticut Unfair Trade Practices Act (CUTPA), alleging that two Aveeno Baby washes were deceptively marketed as containing “natural oat formula” when they allegedly only contained 1% natural ingredients. [read post]
29 Nov 2010, 6:05 pm by M. Brandon Smith
., a subsidiary of Johnson & Johnson, recalled two models of hip implants. [read post]
22 Aug 2012, 11:13 am
Johnson & Johnson, a leading pharmaceutical and medical device manufacturer, as well as a prominent producer of personal care products, announced last week its plans to remove harmful substances, including formaldehyde from its consumer products. [read post]
27 Feb 2012, 5:40 pm
DePuy Orthopedics was acquired by the well-known parent company Johnson & Johnson in 1998. [read post]
28 Feb 2022, 4:00 am by Moll Law Group
Elmiron is a drug for bladder pain manufactured by Johnson & Johnson, its subsidiary Janssen Pharmaceuticals, and other parties for eye damages. [read post]
14 May 2025, 12:00 pm by Angelina Kushnarova
He works at Ethicon (a Johnson & Johnson company), specializing in surgical tools like powered staplers and robotic-assisted systems. [read post]
13 Dec 2021, 8:01 am by Dan Bressler
“Jones Day Bid to Represent Bankrupt J&J Talc Unit Under Fire” — “Jones Day LLP’s help creating Johnson & Johnson’s talc liability spinoff should disqualify the firm from serving as the unit’s lead bankruptcy counsel, the Justice Department and thousands of talc injury claimants said. [read post]